The inhibition of metastasis by fisetin (5 μM) has been suggested through the reduced expression of MMP-2 and MMP-9 enzymes, as observed in BC cell cultures (4T1 and JC cells) treated with this flavonol [122]. The gene discussed is MMP9; the disease is breast cancer.